Investigating the Impact of Humiome B2 (Colon Delivered Riboflavin) and Riboflavin-overproducer Probiotic Strain Limosilactobacillus Reuteri AMBV339 on Intestinal and Vaginal Microbiome and Health of Healthy Adult Women (The VIAB2L Project)
Clinical trial NCT06425081 · COMPLETED
Trial details
- NCT number
- NCT06425081
- Sponsor
- dsm-firmenich Switzerland AG
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-09
- Primary completion
- 2025-01-30
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.